Brain cancer survivors: can a home program boost your memory?

NCT ID NCT06930846

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study tests a home-based program called HOBSCOTCH-CA for brain cancer survivors who struggle with memory and thinking. The program involves weekly virtual sessions with a coach, teaching problem-solving and relaxation techniques. Researchers will compare two groups: one that starts the program right away and another that waits three months. The goal is to see if the program improves quality of life and reduces caregiver burden.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW GRADE GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dartmouth-Health Lebanon

    RECRUITING

    Lebanon, New Hampshire, 03756, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

HOBSCOTCH-CA (a home-based cognitive training and self-management program)

What this could lead to

If it works, this could provide a practical, accessible way for brain cancer survivors to manage memory problems and improve their daily quality of life.

What could go wrong

This is a small, early-stage study (125 participants) with no control group receiving a placebo. The program requires significant time and effort, and results may not apply to all survivors.

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm Caregiver Burden cognitive disorder Cognitive Dysfunction IDH-mutant anaplastic astrocytoma low grade glioma low-grade astrocytoma Memory Disorders meningioma oligodendroglioma primary brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.